MetaCap

ClearPoint Neuro (CLPT) vs K2 Capital Acquisition (KTWO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

ClearPoint Neuro is the larger company by market cap ($221.5 million vs $203.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CLPT-49.34%KTWO+2.53%
+39%-7%-54%
Feb 26, 20261 yearNov 19, 2026
CLPT-45.03%KTWO+2.64%
+54%+2%-50%
Feb 23, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CLPT versus KTWO key metrics
MetricCLPTKTWO
Share price$6.91$10.13
Market cap$221.49M$203.02M
1-day change-5.47%0.00%
YTD return-49.49%—
1-year return-50.00%—
5-year return-50.04%—
EPS (TTM)$-1.21—
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$36.97M—
Revenue growth (YoY)+17.78%—
Net income (latest FY)$-25.54M—
Gross margin61.38%—
Operating margin-65.36%—
Net margin-69.08%—
52-week high$19.63$10.13
52-week low$6.85$0.00
Distance from 52-week high-64.80%0.00%
Analyst consensusnone—
Avg. price target upside+211.14%—
Average volume701.64K17.07K
Shares outstanding32.05M14.13M
Employees172—
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About ClearPoint Neuro

CLPT stock →

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.

Health Care · Medical/Dental Instruments · 172 employees

About K2 Capital Acquisition

KTWO stock →

K2 Capital Acquisition Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the physical AI or energy transition sectors.

Health Care · Medical/Dental Instruments

CLPT vs KTWO FAQ

Which is bigger, ClearPoint Neuro or K2 Capital Acquisition?

ClearPoint Neuro (CLPT) is larger, with a market capitalization of $221.49M compared with $203.02M for K2 Capital Acquisition (KTWO).

Are ClearPoint Neuro and K2 Capital Acquisition in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons